RE:RE:Stagezero (Genenews) Patents - using mRNA and markersLL is right IainC. Stage has a patent for measuring severity and outcome of HF based on upregulation of RNA markers. We currently already measure probability of HF using a peptide marker. Stage may be offering more a refined severity/probability algorithm. The thought of a introducing broad panel keeps me interested in this stock. Imagine instead of ordering a CHEM 12, we'll be ordering a STAGE 10!